Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Paul Thompson MD
Paul D. Thompson MD Advisory Board
Joerg Herrmann MD
Joerg Herrmann MD Associate Editor
J. William McEvoy MB BCh BAO, MEd, MHS, PhD, FRCPI
J. William McEvoy MB BCh BAO, MEd, MHS, PhD, FRCPI Advisory Board
See All Experts
featured
Published in Cardiology and
1 other channel

Journal Scan / Research · September 13, 2018

Modulation of the Interleukin-6 Signaling Pathway Affects Rates of Atherosclerotic Events and Mortality

European Heart Journal

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

Peter Libby MD

European Heart Journal
Modulation of the Interleukin-6 Signalling Pathway and Incidence Rates of Atherosclerotic Events and All-Cause Mortality: Analyses From the Canakinumab Anti-Inflammatory Thrombosis Outcomes Study (CANTOS)
Eur Heart J 2018 Aug 26;[EPub Ahead of Print], PM Ridker, P Libby, JG MacFadyen, T Thuren, C Ballantyne, F Fonseca, W Koenig, H Shimokawa, BM Everett, RJ Glynn

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Recently Updated